11-64758371-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005609.4(PYGM):​c.425-22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0306 in 1,612,576 control chromosomes in the GnomAD database, including 1,164 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 75 hom., cov: 32)
Exomes 𝑓: 0.031 ( 1089 hom. )

Consequence

PYGM
NM_005609.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.00500
Variant links:
Genes affected
PYGM (HGNC:9726): (glycogen phosphorylase, muscle associated) This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 11-64758371-G-A is Benign according to our data. Variant chr11-64758371-G-A is described in ClinVar as [Benign]. Clinvar id is 259836.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64758371-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0647 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PYGMNM_005609.4 linkuse as main transcriptc.425-22C>T intron_variant ENST00000164139.4 NP_005600.1
PYGMNM_001164716.1 linkuse as main transcriptc.244-105C>T intron_variant NP_001158188.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PYGMENST00000164139.4 linkuse as main transcriptc.425-22C>T intron_variant 1 NM_005609.4 ENSP00000164139 P1P11217-1
PYGMENST00000377432.7 linkuse as main transcriptc.244-105C>T intron_variant 2 ENSP00000366650 P11217-2

Frequencies

GnomAD3 genomes
AF:
0.0249
AC:
3793
AN:
152064
Hom.:
73
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00814
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0676
Gnomad ASJ
AF:
0.00692
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.0174
Gnomad FIN
AF:
0.0166
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0302
Gnomad OTH
AF:
0.0230
GnomAD3 exomes
AF:
0.0370
AC:
9269
AN:
250742
Hom.:
423
AF XY:
0.0330
AC XY:
4475
AN XY:
135598
show subpopulations
Gnomad AFR exome
AF:
0.00764
Gnomad AMR exome
AF:
0.134
Gnomad ASJ exome
AF:
0.00526
Gnomad EAS exome
AF:
0.000490
Gnomad SAS exome
AF:
0.0147
Gnomad FIN exome
AF:
0.0193
Gnomad NFE exome
AF:
0.0299
Gnomad OTH exome
AF:
0.0339
GnomAD4 exome
AF:
0.0312
AC:
45513
AN:
1460394
Hom.:
1089
Cov.:
34
AF XY:
0.0304
AC XY:
22073
AN XY:
726598
show subpopulations
Gnomad4 AFR exome
AF:
0.00511
Gnomad4 AMR exome
AF:
0.124
Gnomad4 ASJ exome
AF:
0.00662
Gnomad4 EAS exome
AF:
0.00139
Gnomad4 SAS exome
AF:
0.0146
Gnomad4 FIN exome
AF:
0.0187
Gnomad4 NFE exome
AF:
0.0320
Gnomad4 OTH exome
AF:
0.0277
GnomAD4 genome
AF:
0.0250
AC:
3803
AN:
152182
Hom.:
75
Cov.:
32
AF XY:
0.0247
AC XY:
1835
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.00811
Gnomad4 AMR
AF:
0.0682
Gnomad4 ASJ
AF:
0.00692
Gnomad4 EAS
AF:
0.00174
Gnomad4 SAS
AF:
0.0176
Gnomad4 FIN
AF:
0.0166
Gnomad4 NFE
AF:
0.0302
Gnomad4 OTH
AF:
0.0223
Alfa
AF:
0.0156
Hom.:
8
Bravo
AF:
0.0296
Asia WGS
AF:
0.0110
AC:
39
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJan 29, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 16, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
13
DANN
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61884454; hg19: chr11-64525843; API